Ashland Inc.
Ashland Inc. is classed by the SEC under Wholesale-Chemicals & Allied Products (industry code 5160), based in Wilmington, DE. In its latest annual figures on file, for the fiscal year ended 2025-09-30, it reported revenue of $1.8 billion and a loss of $845 million (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a distribution business: prior from its industry code (SEC 5160, Wholesale-Chemicals & Allied Products); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 4.3 out of ten, 9 of 9 metrics filed: past 5.9 out of ten, present 3.6 out of ten, future 4.1 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 7.1 out of ten. No warning events in its filings since 2017. 71st percentile among 36 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 1.9 out of ten. -5.4% a year over 10 filed years; profitable in 7 of 10. 19th percentile among 35 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 9.6 out of ten. Share count shrank 6.3% a year. 100% of cash flow returned. Insiders: 0 sales, 0 purchases. 96th percentile among 25 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Financial health (present): 4.9 out of ten. ROE -44%: lost 44¢ per shareholder dollar. Leverage 59%: owes 59¢ per asset dollar. 49th percentile among 32 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 2.9 out of ten. bottom 29% of 35 in its family; net margin -46.3%. 29th percentile among 35 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 3.2 out of ten. bottom 32% of 22 in its family for leadership; chief executive since 2020. 32nd percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
- Room to expand (future): 5.7 out of ten. top 43% of 34 in its family for room to expand. 57th percentile among 34 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 5.1 out of ten. top 49% of 35 in its family for growth drivers. 51st percentile among 35 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 1.3 out of ten. bottom 13% of 31 in its family for expectations against reality. 13th percentile among 31 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2025-11-20 for the period ended 2025-09-30 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-07-29 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-07-28 (on EDGAR). Newest filing: Form 4, 2026-10-01. Filings on record since 2016. Read from EDGAR 2026-10-12.
Where the revenue comes from
By geography: Outside the United States 75%, United States 25%. As tagged in its annual report (Form 10-K, filed 2025-11-20).
Who runs it
Novo, Guillermo (Chair of the Board and CEO); Whitaker, William (SVP, CFO & PFO); Drury, Eileen (SVP and Chief HRO); Musa, Osama M (SVP and CTO); Lampkin, Robin E. (SVP, GC & Secretary); Assis, Alessandra Faccin (SVP and GM, Life Sciences); Minicucci, James P. (SVP and GM, Personal Care); Caceres, Dago (SVP & GM, Specialty Additives); Richardson, Samuel (VP, Controller and PAO); Bishop, Steven D (director); and 9 more. 19 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-10-01.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.